'Right-to-try' bill fails to muster votes, dies in the House (for now)

The con­tro­ver­sial right-to-try bill, a di­vi­sive piece of leg­is­la­tion that would have giv­en ter­mi­nal­ly ill pa­tients ac­cess to ex­per­i­men­tal drugs with­out FDA au­tho­riza­tion, was re­ject­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.